Nutrien Q2FY26 Results: EBITDA rises 6%, buybacks accelerate
- Nutrien reported Q2 2026 adjusted EBITDA of $2.4 billion, with H1 total rising 6% YoY to $3.5 billion.
- Potash sales volume guidance was raised to 14.2-14.8 million tons; capex guidance lowered by $50 million.
- Share repurchases accelerated to $75 million per month in Q3, up from ~$50 million per month earlier in the year.
- Retail H1 adjusted EBITDA grew 4% YoY to $1.24 billion, driven by proprietary products despite lower fertilizer volumes.
- The company generated ~$1 billion from asset divestitures since late 2024 and is reviewing strategic alternatives for its phosphate business.

*this image is generated using AI for illustrative purposes only.
Nutrien (TSX: NTR) reported second-quarter 2026 adjusted EBITDA of $2.4 billion, with first-half adjusted EBITDA rising 6% year-over-year to $3.5 billion. The fertilizer producer raised its full-year potash sales volume guidance and accelerated share repurchases to approximately $75 million per month in the third quarter.
Financial Performance
Cash provided by operating activities increased 12% in the first half of 2026, supporting the company’s capital allocation priorities. Management reduced capital expenditures guidance by $50 million to a range of $1.95 billion to $2.05 billion for the full year.
| Segment | Q2 Adjusted EBITDA | H1 Performance Note |
|---|---|---|
| Potash | $658 million | Controllable cash cost flat YoY |
| Nitrogen | $635 million | Volumes down due to maintenance |
| Retail | N/A (H1: $1.24 billion) | H1 EBITDA up 4% YoY |
The potash segment benefited from higher global benchmarks and strong operational execution, maintaining controllable cash costs flat compared to the prior year. The nitrogen segment saw lower sales volumes due to planned maintenance at the Carsland facility and deferred customer purchases, though net selling prices aligned with higher global benchmarks. Phosphate adjusted EBITDA declined in the quarter due to elevated sulfur costs.
Strategic Updates
Nutrien generated approximately $1 billion in gross proceeds from asset divestitures since the fourth quarter of 2024, enhancing portfolio quality. The company is reviewing strategic alternatives for its phosphate business and has received numerous non-binding bids. Additionally, management is evaluating options for its Trinidad nitrogen operations and components of the Brazilian retail business.
What the Numbers Show
The retail segment demonstrates a clear shift in revenue drivers. While domestic commodity fertilizer volumes declined in the second quarter—phosphate down 10% and nitrogen down 7%—proprietary crop nutrients gross margin increased 10% in the first half. This divergence indicates that growth in high-margin proprietary products is offsetting volume weakness in traditional commodity fertilizers, supporting the maintenance of full-year retail adjusted EBITDA guidance at $1.75 billion to $1.95 billion.
Outlook
Global potash shipments are forecast at 74 million to 77 million tons for 2026. Nutrien raised the bottom end of its own potash sales volume guidance to 14.2 million to 14.8 million tons, citing healthy demand across major markets and favorable affordability. The company plans to host an Investor Day on November 30 to outline future growth opportunities.
How might the accelerated share repurchase program impact Nutrien's balance sheet flexibility if global potash prices face volatility in the latter half of 2026?
What specific strategic alternatives is Nutrien likely to pursue for its phosphate business given the receipt of numerous non-binding bids and elevated sulfur costs?
Will the shift toward high-margin proprietary crop nutrients in the retail segment be sufficient to fully offset long-term structural declines in traditional commodity fertilizer volumes?































